Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

ClinicalTrials.gov ID: NCT04617002

Public ClinicalTrials.gov record NCT04617002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04617002
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • ONC201 (dordaviprone) Drug

Drug

Eligibility (public fields only)

Age range
0 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 19, 2025

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
BMDACC at Banner University Medical Center Phoenix Phoenix Arizona 85006
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027
Children's Hospital of Orange County Orange California 92868
Rady Children's Hospital San Diego California 92123
Providence Saint John's Health Center Santa Monica California 90404
Children's Hospital of Colorado Aurora Colorado 80045
Children's National Medical Center Washington D.C. District of Columbia 20010
Miami Cancer Institute Miami Florida 33176
University Cancer & Blood Center Athens Georgia 30607
Kapi'olani Medical Center for Women and Children Honolulu Hawaii 96826
Lurie Children's Hospital Chicago Illinois 60661
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Michigan Ann Arbor Michigan 48109
Washington University in St. Louis St Louis Missouri 63110
University of Nebraska Medical Center - Adults Only Omaha Nebraska 68198
Overlook Medical Center/ Atlantic Health System Summit New Jersey 07901
Albany Medical Center Albany New York 12208
New York University Langone - Active, Enrolling New York New York 10016
University of Rochester Rochester New York 14627
Providence Neurological Specialties Clinic Portland Oregon 97225
University of Texas Southwestern Dallas Texas 75390
Huntsman Cancer Institute Salt Lake City Utah 84112
Children's Hospital of The King's Daughters Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04617002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04617002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →